BioRestorative Therapies, Inc. financial data

Symbol
BRTX on Nasdaq
Industry
Services-Misc Health & Allied Services, NEC
Location
40 Marcus Drive, Melville, NY
Fiscal year end
December 31
Former names
Stem Cell Assurance, Inc. (to 8/16/2011)
Latest financial report
10-Q - Q2 2024 - Aug 13, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 388 % +118%
Debt-to-equity 31.3 % -72%
Return On Equity -32.9 % +88.6%
Return On Assets -25.1 % +81.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 6.77M shares +45%
Common Stock, Shares, Outstanding 6.92M shares +73.8%
Entity Public Float 13.7M USD +60.8%
Common Stock, Value, Issued 692 USD +73.4%
Weighted Average Number of Shares Outstanding, Basic 8.12M shares +109%
Weighted Average Number of Shares Outstanding, Diluted 8.12M shares +109%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 174K USD +35.5%
Research and Development Expense 4.25M USD +11.9%
General and Administrative Expense 8.82M USD -39.2%
Operating Income (Loss) -12.9M USD +29.1%
Nonoperating Income (Expense) 9.12M USD +43.8%
Net Income (Loss) Attributable to Parent -3.79M USD +82%
Earnings Per Share, Basic 0.1 USD/shares +66%
Earnings Per Share, Diluted 0.1 USD/shares +66%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 2.25M USD +26.3%
Marketable Securities, Current 12.4M USD +26.4%
Accounts Receivable, after Allowance for Credit Loss, Current 27.4K USD +9.6%
Assets, Current 15M USD +24.6%
Property, Plant and Equipment, Net 346K USD +10.1%
Operating Lease, Right-of-Use Asset 78.1K USD -57.5%
Intangible Assets, Net (Excluding Goodwill) 669K USD -11.8%
Assets 16.1M USD +21.2%
Accounts Payable, Current 216K USD -21.8%
Accrued Liabilities, Current 448K USD +15.9%
Liabilities, Current 5.32M USD -49.7%
Operating Lease, Liability, Noncurrent 42.4K USD -78.7%
Liabilities 5.32M USD -50.1%
Retained Earnings (Accumulated Deficit) -153M USD -2.54%
Stockholders' Equity Attributable to Parent 10.8M USD +308%
Liabilities and Equity 16.1M USD +21.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.32M USD +2.59%
Net Cash Provided by (Used in) Financing Activities 7.52M USD
Net Cash Provided by (Used in) Investing Activities -4.93M USD -294%
Common Stock, Shares Authorized 75M shares 0%
Common Stock, Shares, Issued 6.92M shares +73.8%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 273K USD +70.6%
Deferred Tax Assets, Valuation Allowance 31.8M USD +14.6%
Deferred Tax Assets, Gross 32.1M USD +14.8%
Operating Lease, Liability 83.6K USD -64.3%
Payments to Acquire Property, Plant, and Equipment 60K USD -45.2%
Lessee, Operating Lease, Liability, to be Paid 86.5K USD -66.3%
Property, Plant and Equipment, Gross 1.37M USD +14.3%
Operating Lease, Liability, Current 83.6K USD -44.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 173K USD +3%
Lessee, Operating Lease, Liability, to be Paid, Year One 173K USD +3%
Operating Lease, Weighted Average Discount Rate, Percent 0.12 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 2.95K USD -87.2%
Deferred Tax Assets, Operating Loss Carryforwards 14.3M USD +8.42%
Preferred Stock, Shares Authorized 20M shares 0%
Operating Lease, Payments 43.3K USD +3%
Additional Paid in Capital 164M USD +7.87%
Amortization of Intangible Assets 22.4K USD +20.4%
Depreciation, Depletion and Amortization 39.4K USD +51.3%
Share-based Payment Arrangement, Expense 324K USD -78.2%
Interest Expense 28.8K USD -94.2%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%